Epidural Nalbuphine for Postcesarean Epidural Morphine Induced Pruritus
NCT ID: NCT00707824
Last Updated: 2008-07-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
165 participants
INTERVENTIONAL
2000-06-30
2006-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy of Intramuscular Naloxone 0.4mg. in Prophylaxis of Intrathecal Morphine Induced Pruritus After Cesarean Section
NCT00890942
Epidural Dexmedetomidine vs Nalbuphine for Labor Analgesia
NCT05327088
Epidural Low Dose Morphine in Postoperative Pain After Posterior Lumbar Spinal Surgery
NCT02067338
Comparison of Surgical Rectus Sheath Block and Intrathecal Morphine
NCT02790099
Propofol for Prophylaxis of Morphine Induced Pruritis in Caesarean Section
NCT06188546
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
After the umbilical cord was clamped,patients were assigned randomly to three groups.The placebo group,N-5 group,and N-10 group received 4 ml epidural solution containing morphine 4 mg plus either saline, nalbuphine 5 mg, and nalbuphine 10 mg respectively.At the post anesthetic care unit, intravenous pethidine PCA were administered for inadequate pain control.
Outcome measures :
Incidence and severity of postoperative pruritus Quality of pain control Side effects of epidural morphine and nalbuphine such as respiratory depression,sedation
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
FACTORIAL
PREVENTION
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
1= placebo
NSS
NSS
2
2=nalbuphine 5 mg
nalbuphine
nalbuphine 5 mg epidural
3
3=nalbuphine 10 mg
nalbuphine
nalbuphine 10 mg epidural
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
nalbuphine
nalbuphine 5 mg epidural
nalbuphine
nalbuphine 10 mg epidural
NSS
NSS
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* ASA 1-2
Exclusion Criteria
* contraindication for regional anesthesia
* received opioids within 12 hours
20 Years
40 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mahidol University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mahidol University
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Orawan Pongraweewan, MD
Role: PRINCIPAL_INVESTIGATOR
Mahidol University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mahidol University
Bangkoknoi, Bangkok, Thailand
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
110/2000
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.